NEW YORK, Jan. 17, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Epidemiology: Non-Small Cell Lung Cancer – Despite global efforts to stop smoking, incidence rates will remain unchanged

http://www.reportlinker.com/p0760640/Epidemiology-Non-Small-Cell-Lung-Cancer-–-Despite-global-efforts-to-stop-smoking-incidence-rates-will-remain-unchanged.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

Introduction Smoking is the leading cause of lung cancer, responsible for 95% of all cases. Global efforts to stop smoking have stabilized over the last decade. Datamonitor epidemiologists expect the number of total incident cases of non-small cell lung carcinoma to remain stable in the seven major markets over the next 10 years.Features and benefits * Gain insight into market potential, including a robust 10-year epidemiology forecast of non-small cell lung cancer.

* Understand the key epidemiologic risk factors associated with non-small cell lung cancer.

Highlights Most people are not diagnosed with lung cancer until the disease has advanced to later-stage illness, making it difficult to treat the cancer successfully and greatly impacting 5-year survival rates for the disease. Smoking cessation is the most effective measure in reducing the risk of non-small cell lung cancer.

For newly diagnosed non-small cell lung cancer in the seven major markets, adults aged 70–74 will have the largest number of total incident cases (80,310 cases), followed by adults ages 65–69 and 75–79 (73,500 cases and 71,300 cases, respectively).

Your key questions answered * What are the most robust sources for non-small cell lung cancer incidence data?

* How will the patient population change through to 2020 in the US, Japan, and the five major EU markets (France, Germany, Italy, Spain, and the UK)?

* How do changes in population structure and risk factors affect the trend in incident non-small cell lung cancer cases?

Executive Summary

Disease background

Forecasted results

OVERVIEW

Catalyst

Summary

DISEASE DEFINITION AND DIAGNOSTIC CRITERIA

Overview of lung cancer

Classification of non-small cell lung cancer

Metastasis

Staging

Signs and symptoms of lung cancer

Diagnostic criteria for lung cancer

GLOBAL VARIATION AND HISTORICAL TRENDS

Incidence rates reflect exposure to tobacco smoke

Survival rates for lung cancer are the lowest of any cancer

Mortality rates are nearly equivalent to incident cases

Prevalence

DRIVERS OF NON-SMALL CELL LUNG CANCER EPIDEMIOLOGY

Up to 95% of lung cancer cases could be eliminated if smoking were eradicated

Other environmental factors may work synergistically with smoking to increase lung cancer risk

Current screening methods do not improve survival

Late presentation and diagnosis limit treatment options to surgery

EPIDEMIOLOGIC FORECASTING OF NON-SMALL CELL LUNG CANCER

Overview

Population denominators

Cancer registries: age- and sex-specific incidence rates

Subpopulations

Age

Stage

Description of methods

Statistical analysis

US

Japan

France

Germany

Italy

Spain

UK

EPIDEMIOLOGIC RESULTS

Diagnosed incident cases of lung cancer (all types)

The number of incident cases of lung cancer (all types) will remain stable from 2010 to 2020

German men will have the highest age-standardized incidence rate of lung cancer (all types)

Segmentation of incident lung cancer cases (all types) in 2010

Total incident cases of non-small cell lung cancer

The number of incident cases of NSCLC will remain stable from 2010 to 2020

Spanish women will have the lowest age-standardized incidence rate of NSCLC

Segmentation of incident non-small cell lung cancer in 2010

DISCUSSION

The strength of Datamonitor's epidemiologic projections

BIBLIOGRAPHY

Journal articles

Websites

APPENDIX

Module methodology

To order this report:Pathology Industry: Epidemiology: Non-Small Cell Lung Cancer – Despite global efforts to stop smoking, incidence rates will remain unchanged

More  

Market Research Report

Check our  

Industry Analysis and Insights

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker

Back to top

RELATED LINKS
http://www.reportlinker.com